Sawant Abhishek C, Bhardwaj Aishwarya, Srivatsa Shantanu, Sridhara Srilekha, Prakash Meghana Prakash Hiriyur, Kanwar Nidhi, Rodriguez Janelle, Tse Gary, Liu Tong, Kumar Arnav, Beck Hiroko, Srivatsa Sanjay S
Division of Interventional Cardiology, Banner University Medical Center, Phoenix, AZ, USA.
Division of Cardiology, State University of New York at Buffalo, Buffalo, NY, USA.
Indian Heart J. 2019 Nov-Dec;71(6):481-487. doi: 10.1016/j.ihj.2019.09.008. Epub 2019 Sep 9.
Frontal QRS-T angle (FQRST) has previously been correlated with mortality in patients with stable coronary artery disease, but its role as survival predictor after ST-elevation myocardial infarction (STEMI) remains unknown.
We evaluated 267 consecutive patients with STEMI undergoing reperfusion or coronary artery bypass grafting. Data assessed included demographics, clinical presentation, electrocardiograms, medical therapy, and one-year mortality.
Of 267 patients, 187 (70%) were males and most (49.4%) patients were Caucasian. All-cause mortality was significantly higher among patients with the highest (101-180°) FQRST [28% vs. 15%, p = 0.02]. Patients with FQRST 1-50° had higher survival (85.6%) compared with FQRST = 51-100° (72.3%) and FQRST = 101-180° (67.9%), [log rank, p = 0.01]. Adjusting for significant variables identified during univariate analysis, FQRST (OR = 2.04 [95% CI: 1.31-13.50]) remained an independent predictor of one-year mortality. FQRST-based risk score (1-50° = 0 points, 51-100° = 2 points, 101-180° = 5 points) had excellent discriminatory ability for one-year mortality when combined with Mayo Clinic Risk Score (C statistic = 0.875 [95%CI: 0.813-0.937]. A high (>4 points) FQRST risk score was associated with greater mortality (32% vs. 19%, p = 0.02) and longer length of stay (6 vs. 2 days, p < 0.001).
FQRST represents a novel independent predictor of one-year mortality in patients with STEMI undergoing reperfusion. A high FQRST-based risk score was associated with greater mortality and longer length of stay and, after combining with Mayo Clinic Risk Score, improved discriminatory ability for one-year mortality.
额面QRS-T角(FQRST)此前已被证实与稳定型冠状动脉疾病患者的死亡率相关,但其在ST段抬高型心肌梗死(STEMI)后作为生存预测指标的作用仍不明确。
我们评估了267例连续接受再灌注治疗或冠状动脉旁路移植术的STEMI患者。评估的数据包括人口统计学资料、临床表现、心电图、药物治疗及一年死亡率。
267例患者中,187例(70%)为男性,大多数(49.4%)患者为白种人。FQRST最高(101-180°)的患者全因死亡率显著更高[28%对15%,p = 0.02]。FQRST为1-50°的患者生存率更高(85.6%),相比之下,FQRST为51-100°的患者生存率为72.3%,FQRST为101-180°的患者生存率为67.9%,[对数秩检验,p = 0.01]。在对单因素分析中确定的显著变量进行校正后,FQRST(比值比=2.04[95%置信区间:1.31-13.50])仍然是一年死亡率的独立预测指标。基于FQRST的风险评分(1-50°=0分,51-100°=2分,101-180°=5分)与梅奥诊所风险评分联合使用时,对一年死亡率具有出色的鉴别能力(C统计量=0.875[95%置信区间:0.813-0.937])。高(>4分)FQRST风险评分与更高的死亡率(32%对19%,p = 0.02)和更长的住院时间(6天对2天,p < 0.001)相关。
FQRST是接受再灌注治疗的STEMI患者一年死亡率的新型独立预测指标。基于FQRST的高风险评分与更高的死亡率和更长的住院时间相关,并且与梅奥诊所风险评分联合使用后,提高了对一年死亡率的鉴别能力。